Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lilly’s Latest Partner

Albany Molecular Research Inc. will hire 40 chemists to aid drugmaker's discovery efforts

by Ann M. Thayer
November 14, 2011 | A version of this story appeared in Volume 89, Issue 46

Eli Lilly & Co. has formed a partnership with Albany Molecular Research Inc. that furthers its creation of an outsourcing network. AMRI scientists will work at Lilly’s Indianapolis headquarters to support the drug company’s medicinal chemistry department.

To do the work, AMRI intends to hire more than 40 full-time synthetic chemists by the third quarter of 2012. It expects to recruit the majority of these chemists from Indiana and nearby states. The initial term of the companies’ collaboration is six years.

“Our partnership with AMRI is another example of how Lilly is transforming the way it conducts R&D, enabling our scientists to discover potential new medicines in as proficient a manner as possible,” says Alan D. Palkowitz, Lilly’s vice president for discovery, chemistry, research, and technologies.

No Lilly jobs will be affected by the deal, according to a Lilly spokeswoman. Instead, Lilly is consolidating and augmenting work that had been outsourced to other contract research firms. Having chemists on-site will simplify project management, maximize resources, and reduce overhead costs, she adds.

In the past two years, Lilly has set up many long-term outsourcing contracts, often involving its operations in Indiana. Covance provides clinical-trial support from Lilly’s former Greenfield location. Advion BioSciences built a new lab to house bioanalytical capabilities that Lilly transferred to it. Thermo Fisher Scientific has taken over Lilly’s in-house clinical-trial-materials manufacturing. And Evonik Industries supplies pharmaceutical ingredients from the Tippecanoe Laboratories site.

Altogether, these deals have kept about 1,000 former Lilly workers employed. The company has targeted 5,500 job cuts by the end of 2011.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.